Literatur
- 1
European guidelines on
cardiovascular disease prevention in clinical practice.
Eur Heart
J.
2007;
28
2375-2414
- 2
Berger J S. et al .
Aspirin for the primary prevention of cardiovascular
events in women and men.
JAMA.
2006;
295
306-313
- 3
Sacco. et al .
Primary prevention of cardiovascular events with low-dose aspirin
and vitamine E in type 2 diabetic patients.
Diabetics
Care.
2003;
26
3264-3272
- 4
Cleland J.
Is aspirin „the weakest link” in cardiovascular
prophylaxis? The surprising lack of evidence supporting the use
of aspirin for cardiovascular disease.
Progr cardiovasc
dis.
2002;
44
275-292
- 5
Conroy R. et
al .
Estimation of ten-year risk of fatal cardiovascular
disease in Europe: the SCORE-project.
Eur Heart J.
2003;
24
987-1003
- 6
Diaz S. et
al .
Cardioprotective aspirin users and their excess
risk of upper gastrointestinal complications.
BMC Medicine.
2006;
4
22
PD Dr. med. Jochen Müller-Ehmsen
Prof. Dr. med. Erland Erdmann
Herzzentrum der Universität zu Köln, Direktor
der Klinik für Kardiologie, Angiologie, Pneumologie
und Internistische Intensivmedizin
Kerpener Str. 62
D-50937 Köln / Germany
Phone: +49
221 478 32511
Fax: +49 221 478 32512
Email: erland.erdmann@uni-koeln.de
URL: http://www.herzzentrum-koeln.de
